Vaccine-modified measles in previously immunized children in Accra, Ghana: clinical, virological and serological

N Ishiwada1, M M Addae, J K Tetteh

  • 1Department of Paediatrics, Chiba University School of Medicine, Chiba, Japan.

Insights

Measles outbreaks in Ghana showed milder symptoms in vaccinated children, indicating waning immunity. Further research suggests multiple measles vaccine doses may be needed for sustained protection.

Area of Science:

  • Epidemiology
  • Immunology
  • Public Health

Background:

  • Measles outbreaks occurred in Accra, Ghana, despite high immunization coverage.
  • 44 cases of acute measles were diagnosed and examined clinically and serologically.

Purpose of the Study:

  • To investigate the clinical and serological characteristics of measles cases during outbreaks in Accra.
  • To understand the reasons behind measles outbreaks in an area with high vaccination rates.

Main Methods:

  • Clinical examination of 44 measles cases.
  • Serological testing for measles IgM and IgG antibodies during the acute phase.

Main Results:

  • Peak incidence of measles was observed in 6-12-year-olds.
  • Clinical symptoms were milder than typical measles, with less frequent fever.
  • Serological tests revealed the presence of measles IgG antibodies in 84.2% of cases, suggesting vaccine-modified measles.

Conclusions:

  • Milder symptoms and presence of IgG antibodies indicate vaccine-modified measles, possibly due to waning immunity.
  • Accurate diagnosis requires serological confirmation, especially in high-vaccination areas.
  • Multiple measles vaccine doses may be necessary in Ghana to maintain protective antibody levels and prevent future outbreaks.